Calling all Canadian & Israeli early-stage innovators in the cardiovascular devices and digital heart health space! The Canada-Israel Cardiovascular Innovation Forum is holding a competition that will link top ranking innovators with interested investors. cicvinnovation.com/
We congratulate WNICER's Dr. Sanjay Rajagopalan on receiving the @ACCinTouch Distinguished Scientist (Translational Domain) Award! Thanks Sanjay for helping to transform cardiovascular care and improve the heart health of patients worldwide. Read details: wnicer.org/news
WNICER congratulates @ATTACC_COVID team & WNICER members @PatrickLawlerMD @drmikefarkouh on the release of interim analysis results showing that full-dose blood thinners decreased need for life support & improved outcomes in hospitalized COVID-19 patients wnicer.org/news
WNICER retweeted
An incredible multi-country effort led by #Canadian researchers that will improve outcomes for patients with #COVID19 worldwide, and decrease the incredible strain on our #ICU resources. @PMunkCardiacCtr @uhn @UofT @drmikefarkouh @OntariosDoctors @ONgov
Full dose blood thinners can decrease the need for life support therapies in hospitalized non-ICU #COVID19 patients, according to an international clinical trial co-led by UHN's @PatrickLawlerMD and @ecgoligher & @UM_RadyFHS's @RZarychanski.
More → bit.ly/3sNnXx0
WNICER retweeted
Webinar @DrOz moderated with leaders and doctors from Jewish, Christian & Muslim faiths. Co-hosted by @CuraFdn & @VaticanCultura. Watch at bit.ly/BSF_1. #BridgingScienceandFaith
Science and Faith need to work together as we battle this pandemic. See the Op-Ed @RobinSmithMD and @DrOz worked on. #BridgingScienceandFaith
washingtonexaminer.com/opini…
Clinical evidence shows both micro and macrovascular thrombosis as a result of #Covid19. Follow the link to watch the full webinar we hosted with our partner @Curafdn, moderated by @GomezTV bit.ly/COVID19_Cardiovascula…
Is there such thing as a "full" recovery? Join @drmikefarkouh and guests today at 12PM to hear about the acute & chronic cardiovascular complications of #Covid19. Co-hosted by @CuraFdn and moderated by @GomezTV. zoom.us/webinar/register/221…
If you make it through the illness, your journey may just be starting. Join @drmikefarkouh and guests next Monday at 12PM to hear about the acute & chronic cardiovascular complications of #Covid19.
Register to join us Monday at noon with @WNICERInstitute. We are hosting @drmikefarkouh, Dr. Goonewardena, Dr. Libby and Dr. Rosenson to talk about acute and chronic cardiovascular impacts of #Covid19. Moderated by @GomezTV zoom.us/webinar/register/341…
If you make it through the illness, your journey may just be starting. Join our Founder @drmikefarkouh and guests next Monday at 12PM to hear about the acute & chronic cardiovascular complications of #Covid19. Hosted by @CuraFdn and moderated by @GomezTV. zoom.us/webinar/register/221…
WNICER retweeted
Even after recovery, there're still long-term impacts to health. If you missed Monday's webinar, we hosted Former @US_FDA Commissioner Dr. Andrew von Eschenbach & @drwilliamli in a discussion on #longhaulers & #Covid19. Moderated by @GomezTV. Watch it at bit.ly/COVID-19_Effects
WNICER retweeted
Great to be meeting with colleagues from 🇦🇨 🇨🇦 🇧🇷 🇺🇸 to discuss #clinicaltrials run through the Worldwide Network for Innovation in Clinical Education and Research (WNICER). @drmikefarkouh @VMathewMD @nl_pereira @goodman_shawnn @PMunkCardiacCtr @MayoClinic @UHN @usponline
WNICER retweeted
Continued evidence that bleeding is bad as in our meta analysis
Al Halabi S et al. Meta-Analysis of Studies Comparing Dual- Versus Mono-Antiplatelet Therapy Following TAVR. Am J Cardiol. 2018;122(1):141-148. @shadihalabi4 @Josh2Newman @drmikefarkouh @WNICERInstitute @MartyMleon
Results from the POPULAR TAVI trial demonstrated that omitting #clopidogrel after TAVR may reduce bleeding, and aspirin alone may be sufficient to prevent thromboembolic events #ESCCongress, @ESCardio, @ESCardioNews, #cardiotwitter @NEJM healio.com/news/cardiac-vasc…
WNICER celebrates the publication of TAILOR-PCI in JAMA, highlighting the potential clinical impact of a personalized strategy to managing antiplatelet therapy post PCI. bit.ly/3huCgAN @nl_pereira @drmikefarkouh @VMathewMD @JLBrooks @CuraFdn @RobinSmithMD @DrRSRosenson
How are members of the WNICER Network contributing towards the eradication of #COVID19? By collaborating on research and clinical trials – like the ATTACC Study (Antithrombotic Therapy to Ameliorate Complications of COVID-19). clinicaltrials.gov/ct2/show/…
WNICER targets major global health issues and improves human health through better understanding the interrelationship of chronic diseases. wnicer.org/









